New antifungal antibiotics, benanomicins A and B inhibit infection of T-cell with human immunodeficiency virus (HIV) and syncytium formation by HIV.
Hoshino
H
H
Department of Hygiene, Gunma University, School of Medicine, Japan.
Seki
J
J
Takeuchi
T
T
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D000192:Actinomycetales / Q000378:metabolism*; D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic / Q000302:isolation & purification* / Q000494:pharmacology; D000935:Antifungal Agents / Q000302:isolation & purification* / Q000494:pharmacology; D002460:Cell Line / Q000187:drug effects; D015497:HIV-1 / Q000187:drug effects / Q000472:pathogenicity*; D006801:Humans; D013601:T-Lymphocytes / Q000382:microbiology*; D000095643:Pradimicins and Benanomicins
D018943:Anthracyclines; D000903:Antibiotics, Antineoplastic; D000935:Antifungal Agents; C056805:benanomicin A; D000095643:Pradimicins and Benanomicins; C056806:benanomicin B